The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update

8 Jul 2022 15:55

RNS Number : 9016R
Applied Graphene Materials PLC
08 July 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("EUWA")) ("UK MAR"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF INSIDE INFORMATION (AS DEFINED UNDER UK MAR). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION, WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

8 July 2022

Applied Graphene Materials plc

("Applied Graphene Materials", "the Group" or "the Company")

Update

 

The Company provides the following update.

 

The Company disclosed in its Annual Report and Accounts for the year ended 31 July 2021 that the Company has a cash runway beyond 31 January 2023.

 

In order to raise general awareness of the Company across the investment community ahead of any future equity raise, the Company has appointed Weild & Co acting via its representative Crestmont LLP. The purpose of Crestmont's appointment is to introduce the Company to new potential investors in non-UK jurisdictions but in particular focusing on the USA.

 

The Company appointed Weild & Co to effect these introductions on a general and non-deal specific basis with the process ongoing. The Board has been made aware that, as part of this non-deal process and without the Company's authority or instruction, disclosure has been made to certain of the third parties approached that the Company has engaged Crestmont in relation to an equity raise of up to $10 million.

 

In order to fund the Company's operations and continued development of the business beyond 31 January 2023, the Board confirms its intention to investigate a possible fundraise, quantum and timing to be determined but likely to be over the coming months.

 

The Company will make further announcements as appropriate.

 

 

For further information, please contact:

 

Applied Graphene Materials  +44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

 

Singer Capital Markets  +44 (0) 207 496 3000

Peter Steel / Amanda Gray

 

Allenby Capital Limited  +44 (0) 203 328 5656

Nick Athanas / Liz Kirchner (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

Hudson Sandler +44 (0) 207 796 4133

Nick Lyon / Emily Dillon

 

 

Notes to Editors

 

Applied Graphene Materials  - For the last decade, AGM has been at the forefront of harnessing the possibilities of graphene. Founded originally by Professor Karl Coleman, the Group has grown from an academic idea from Durham University to a world leader in the development and application of graphene nanoplatelet dispersions for customers in the coatings, composites and functional materials sectors.

 

The Group utilises its proprietary bottom-up manufacturing process to produce high purity graphene nanoplatelets. Its expertise in dispersion chemistry enables AGM to create optimised, stable and easy to handle dispersions that customers use in real-world industrial products. AGM's unique approach enables industries to fully realise the potential of graphene in a simple, safe and easy to formulate way. 

 

AGM, based at the Wilton Centre on Teesside, was admitted to AIM in November 2013, raising £11 million. The Group successfully raised £8.5m in January 2016, £9.8m in November 2017 and a further £6m gross in January 2021. The Group's shares are also cross-traded on OTCQX in the United States. As a result of the funding support and its industry leading technology platform, AGM has been able to develop a significant sales distribution network covering Europe, North America and Asia. The Group continues to work closely with industrial partners, and has seen the successful launch of numerous commercial products enhanced by its Graphene Dispersions.

https://www.appliedgraphenematerials.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSSFFLAEESEIW
Date   Source Headline
17th Dec 20197:00 amRNSAGM Statement
30th Oct 20193:48 pmRNSDirector/PDMR Shareholding (correction)
30th Oct 20192:02 pmRNSDirector/PDMR Shareholding
30th Oct 20197:00 amRNSCustomer product launched via leading UK retailer
21st Oct 20193:30 pmRNSAGM presents to investors in Beijing
16th Oct 20197:00 amRNSAnnual Results
9th Oct 20192:00 pmRNSOperational update
3rd Oct 20197:00 amRNSAGM develops composite applications for space
30th Sep 201911:30 amRNSNotice of Annual Results
10th Sep 201912:00 pmRNSAGM to present at technical & investor conferences
5th Aug 20194:41 pmRNSSecond Price Monitoring Extn
5th Aug 20194:36 pmRNSPrice Monitoring Extension
5th Aug 20192:05 pmRNSSecond Price Monitoring Extn
5th Aug 20192:00 pmRNSPrice Monitoring Extension
31st Jul 20197:00 amRNSIssue of share options to Directors
10th Jul 20197:00 amRNSAGM advances applications for water-based coatings
9th Jul 201912:20 pmRNSNew Coatings Product Launch
3rd Jun 20197:00 amRNSAGM sign distribution agreement with Carst&Walker
30th May 20197:00 amRNSAGM to showcase Aerospace composites at NATEP
23rd May 20199:37 amRNSAGM signs distribution agreement with CAME Srl
17th May 20197:00 amRNSAGM secures patent in strategic territory
3rd Apr 20197:00 amRNSInterim Results
21st Mar 20197:00 amRNSAGM to attend Corrosion 2019 Conference & Expo
21st Mar 20197:00 amRNSNotice of Interim Results
14th Mar 20197:24 amRNSAGM to Present at European Coatings Show
7th Mar 201911:05 amRNSSecond Price Monitoring Extn
7th Mar 201911:00 amRNSPrice Monitoring Extension
6th Mar 201910:34 amRNSAppointment to the NGA's Industry Council
28th Feb 201911:43 amRNSBreakthrough anti-corrosion graphene technology
31st Jan 20194:58 pmRNSIssue of share options to Directors
21st Jan 201912:00 pmRNSDirector/PDMR Shareholding
15th Jan 20192:05 pmRNSSecond Price Monitoring Extn
15th Jan 20192:00 pmRNSPrice Monitoring Extension
10th Jan 201912:26 pmRNSHolding(s) in Company
18th Dec 20184:33 pmRNSResult of AGM
18th Dec 20187:00 amRNSAGM Statement
13th Dec 20182:05 pmRNSSecond Price Monitoring Extn
13th Dec 20182:00 pmRNSPrice Monitoring Extension
18th Oct 20187:00 amRNSFinal Results
9th Oct 20188:23 amRNSBoard Appointment
12th Sep 20184:40 pmRNSSecond Price Monitoring Extn
12th Sep 20184:35 pmRNSPrice Monitoring Extension
12th Sep 20182:05 pmRNSSecond Price Monitoring Extn
12th Sep 20182:00 pmRNSPrice Monitoring Extension
28th Aug 20182:17 pmRNSNotice of Annual Results
1st Aug 20187:00 amRNSBoard Change
29th Jun 201810:19 amRNSBoard Changes
22nd May 20184:40 pmRNSSecond Price Monitoring Extn
22nd May 20184:35 pmRNSPrice Monitoring Extension
22nd May 20187:00 amRNSJames Briggs Commercial Agreement & Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.